epitope corresponding to amino acids 2726-2834 of fibrillin-1 of human origin
Modification Notes
The fibrillin family of proteins, including fibrillin 1 (Fbn-1) and fibrillin 2 (Fbn-2), are integral components of a distinct subset of extracellular microfibrils (1,2). Microfibrils are found in elastic tissues where they facilitate elastic fiber formation and in nonelastic tissue where they support the association of the epithelial cells with the interstitial matrix (3). Characteristic of the fibrillin proteins are the epidermal growth factor (EGF)-like motifs which contain a consensus sequence for calcium binding. This calcium association may be critical for protein-protein interactions and stabilization of the microfibrils (4). Mutations of the FBN1 gene have been shown to result in Marfan syndrome, a disease characterized by abnormal synthesis, secretion and matrix deposition of fibrillin (5). FBN2 is also linked to a rare, yet similiar skeletal disorder, congenital contractural arachnodactyly (6).
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of fibrillin-1 of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including equine, canine, bovine and porcine:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 2726-2834 of fibrillin-1 of human origin
Tissue Specificity
epitope corresponding to amino acids 2726-2834 of fibrillin-1 of human origin
Western blot analysis of fibrillin-1 expression in Jurkat whole cell lysate.
Application Notes
recommended for detection of fibrillin-1 of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including equine, canine, bovine and porcine:
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.